Iron Treatment in Chronic Renal Insufficiency

Identifying—and treating—iron deficiency before initiating any other anemia treatment may be the optimal strategy for chronic renal insufficiency (CRI) patients^a

• Regular monitoring of iron parameters is critical in the management of anemia in CRI patients^7,20
  
  
• Evidence suggests that iron deficiency can occur as early as CKD Stage 2²
  
  
• The National Kidney Foundation Kidney Disease Outcomes Quality Initiative (KDOQI^TM) guidelines recommend monitoring TSAT, serum ferritin, and Hgb as early as Stage 3 (GFR <60 mL/min for 3 months with or without kidney damage)^7,20
  
  
• When evaluating the cause of anemia, physicians should also consider iron parameters and Hgb levels before initiating any anemia treatment—including erythropoiesis stimulating agents (ESAs)⁷

^aCRI and chronic kidney disease (CKD) refer to the same condition; terminology differs among medical specialties.

GFR=glomerular filtration rate; Hgb=hemoglobin; TSAT=transferrin saturation.

KDOQI is a trademark of the National Kidney Foundation, Inc.

Now that you know about Iron Treatment in Chronic Renal Insufficiency,
learn more about the Treatment Strategy for IDA.